Bleeding diathesis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 15: | Line 15: | ||
! | ! | ||
! | ! | ||
!History | ! rowspan="2" |History | ||
! colspan="5" |Clinical manifestation | ! colspan="5" |Clinical manifestation | ||
! colspan="5" |Laboratory testing | ! colspan="5" |Laboratory testing | ||
|- | |- | ||
! | ! | ||
! | ! |
Revision as of 16:22, 8 August 2018
Bleeding diathesis main page |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mehrian Jafarizade, M.D [2]
Overview
Classification
Differential Diagnosis
History | Clinical manifestation | Laboratory testing | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Petechiae | Ecchymoses | Menorrhagia | Hematomas | Hemarthrosis | platelet count | Bleeding time (BT) | Prothrombin time (PT) | Platelet count activated partial thromboplastin time (aPTT) | Thrombin time (TT) | |||||
Platelet disorders | Thrombocytopenia | Infection-Induced Thrombocytopenia | ||||||||||||
Drug-Induced Thrombocytopenia | ||||||||||||||
Heparin-Induced Thrombocytopenia | ||||||||||||||
Immune Thrombocytopenic Purpura (ITP) | ||||||||||||||
Inherited Thrombocytopenia | ||||||||||||||
Thrombotic Thrombocytopenic Purpura (TTP) | ||||||||||||||
Hemolytic Uremic Syndrome | ||||||||||||||
Thromobcytosis | Thrombocytosis in response to acute or chronic inflammation has not been associated with an increased thrombotic risk. In fact, patients with markedly elevated platelet counts (>1.5 million), usually seen in the setting of a myeloproliferative disorder, have an increased risk of bleeding. This appears to be due, at least in part, to acquired von Willebrand disease (VWD) due to platelet-VWF adhesion and removal. | |||||||||||||
Qualitative Disorders of Platelet Function | Inherited Disorders of Platelet Function | |||||||||||||
Acquired Disorders of Platelet Function | ||||||||||||||
von Willebrand Disease | Type 1 | |||||||||||||
Type 2 A | ||||||||||||||
Type 2 B | ||||||||||||||
Type 2 M | ||||||||||||||
Type 3 | ||||||||||||||
Vessel wall disorders | Metabolic and Inflammatory Disorders | |||||||||||||
Inherited Disorders of the Vessel Wall | ||||||||||||||
Coagulation disorders | Fibrinogen deficiency | |||||||||||||
Prothrombin deficiency | ||||||||||||||
Factor V deficiency | ||||||||||||||
Factor VII deficiency | ||||||||||||||
Factor VIII deficiency | ||||||||||||||
Factor IX deficiency | ||||||||||||||
Factor X deficiency | ||||||||||||||
Factor XI deficiency | ||||||||||||||
Factor XII deficiency | ||||||||||||||
HK deficiency | ||||||||||||||
Prekallikrein deficiency | ||||||||||||||
Factor XIII deficiency | ||||||||||||||
Hemophilia | Type A deficiency | |||||||||||||
Type B deficiency | ||||||||||||||
Type C deficiency | ||||||||||||||
Rare diseases | Disseminated Intravascular Coagulation | |||||||||||||
Vitamin K Deficiency | ||||||||||||||
Coagulation Disorders Associated with Liver Failure | ||||||||||||||
Acquired Inhibitors of Coagulation Factors |